Bumper Offer - Urjas oil Just @ Rs. 1
Mikasafe is a prescription medicine that is available as a Injection. Primarily, it is used for the treatment of Urinary Tract Infection. Mikasafe also has some secondary and off-label uses. These are listed below.
The optimal dosage of Mikasafe is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Mikasafe have been listed ahead. Such side effects of Mikasafe normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Mikasafe has a Severe effect for pregnant women and Unknown effect on lactating mothers. In addition, Mikasafe's effects on the liver, heart and kidney are discussed below in the Mikasafe related warnings section.
Mikasafe is contraindicated in people with pre-existing medical conditions like Dehydration, Parkinson's Disease, Hearing Loss as it can result in adverse effects. Some other conditions that can be affected by Mikasafe are listed in the contraindications section below.
Drug reaction of Mikasafe with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Mikasafe, it is important to know that it is safe while driving, and is habit-forming.
Mikasafe is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Mikasafe is used -
Moderate
Mild
Unknown
Is the use of Mikasafe safe for pregnant women?
Mikasafe can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Mikasafe safe during breastfeeding?
There is no research available on the side effects of Mikasafe in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Mikasafe on the Kidneys?
Consumption of Mikasafe can harm the kidneys. So it is important to take medical advice beforehand.
What is the effect of Mikasafe on the Liver?
Very few cases of side effects of Mikasafe on the liver have been reported.
What is the effect of Mikasafe on the Heart?
Side effects of Mikasafe rarely affect the heart.
Mikasafe should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Mikasafe unless your doctor advises you to do so -
Is this Mikasafe habit forming or addictive?
Mikasafe does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Mikasafe will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Mikasafe only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Mikasafe for mental disorders.
Interaction between Food and Mikasafe
Taking Mikasafe with food does not cause any problems.
Interaction between Alcohol and Mikasafe
It is difficult to say anything about the effect of Mikasafe and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137